These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 8754879

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
    Chen X, Zhou B, Li M, Deng Q, Wu X, Le X, Wu C, Larmonier N, Zhang W, Zhang H, Wang H, Katsanis E.
    Clin Immunol; 2007 Apr; 123(1):50-9. PubMed ID: 17234458
    [Abstract] [Full Text] [Related]

  • 25. [Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
    Vakhidova GA, Vasil'eva FR, Kurbanova RR, Stepanenko RN, Ubaĭdullaev AM.
    Probl Tuberk; 1990 Apr; (3):16-8. PubMed ID: 2367502
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 29. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE.
    Schweiz Med Wochenschr; 2000 Dec 09; 130(49):1909-13. PubMed ID: 11153397
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG, Chukanov VI, Korneev AA.
    Probl Tuberk; 1996 Dec 09; (6):42-4. PubMed ID: 9019768
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Frequency and clinical importance of primary pharmacoresistance of Mycobacteria in patients with tuberculosis of the lungs].
    Bibik NF.
    Probl Tuberk; 1972 Dec 09; 50(8):20-5. PubMed ID: 4626690
    [No Abstract] [Full Text] [Related]

  • 34. [Effect of glucocorticosteroid hormones on T lymphocytes in patients with pulmonary tuberculosis].
    Basov PV.
    Probl Tuberk; 1989 Dec 09; (4):30-3. PubMed ID: 2786631
    [Abstract] [Full Text] [Related]

  • 35. [Regulatory subpopulations of T lymphocytes in patients with pulmonary tuberculosis].
    Averbakh MM, Eremeev VV, Khomenko IS.
    Probl Tuberk; 1986 Dec 09; (7):50-4. PubMed ID: 2876422
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Effect of acute respiratory viral infection on the indicators of immunity in patients with pulmonary tuberculosis].
    Kossiĭ NV, Gergert VIa, Abramova ZP.
    Probl Tuberk; 1990 Dec 09; (7):33-6. PubMed ID: 2235948
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.